Bumper Offer - Urjas oil Just @ Rs. 1
Rcifax 550 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Hepatic Encephalopathy. Rcifax 550 Tablet also has some secondary and off-label uses. These are listed below.
The correct dosage of Rcifax 550 Tablet depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Rcifax 550 Tablet also has some side effects, the most common being Flatulence, Bloating or fullness, Constipation. Some other side effects of Rcifax 550 Tablet have been listed ahead. These side effects of Rcifax 550 Tablet are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Rcifax 550 Tablet has a Severe effect for pregnant women and Severe effect on lactating mothers. Warnings related to Rcifax 550 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Other conditions have been mentioned below in the Rcifax 550 Tablet contraindications section.
Drug reaction of Rcifax 550 Tablet with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Rcifax 550 Tablet, it is important to know that it is safe while driving, and is habit-forming.
Rcifax 550 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| 13 - 18 years (Adolescent) |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Rcifax 550 Tablet is used -
Moderate
Mild
Common
Is the use of Rcifax 550 Tablet safe for pregnant women?
Rcifax should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Rcifax 550 Tablet safe during breastfeeding?
Rcifax may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Rcifax 550 Tablet on the Kidneys?
There are no side effects of Rcifax on the kidneys.
What is the effect of Rcifax 550 Tablet on the Liver?
Rcifax is rarely harmful for the liver.
What is the effect of Rcifax 550 Tablet on the Heart?
There are no any side effects of Rcifax for the heart.
Rcifax 550 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Rcifax 550 Tablet unless your doctor advises you to do so -
Is this Rcifax 550 Tablet habit forming or addictive?
Forming a habit of Rcifax 550 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Rcifax 550 Tablet since it will not make you feel sleepy.
Is it safe?
Yes, Rcifax 550 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Rcifax 550 Tablet in mental disorders is not effective.
Interaction between Food and Rcifax 550 Tablet
You can take Rcifax 550 Tablet with food.
Interaction between Alcohol and Rcifax 550 Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Rcifax 550 Tablet with alcohol will be.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
